How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
Description:
To control mCRPC that has spread to the bone marrow. The safety and effects of this treatment will also be studied.
Sponsor:
MD Anderson Cancer Center
Contacts:
Bagi Jana, MDbjana@mdanderson.org
713-563-0670
Government Study Link:
NCT07025512 - Click here to see study onClinicalTrials.gov
177Lu-PSMA-617
Isotope(s):
Target(s):
- PSMA
Ligand: Small Molecules
Chelator: DOTA
